New genetic test may uncover hidden nerve disease in patients with unexplained symptoms
NCT ID NCT03720275
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new genetic screening approach to find cases of a rare inherited nerve disease called TTR-FAP in 130 patients with chronic neuropathy of unknown cause. The goal was to see how many of these patients actually have TTR-FAP, which is often missed due to varied symptoms. By using a simple blood test to look for TTR gene mutations, researchers hope to speed up diagnosis and allow earlier treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOID NEUROPATHIES, FAMILIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Reference center for neuromuscular diseases
Bordeaux, 33076, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.